198 related articles for article (PubMed ID: 26260680)
1. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence.
Morancho B; Martínez-Barriocanal Á; Villanueva J; Arribas J
Breast Cancer Res; 2015 Aug; 17(1):106. PubMed ID: 26260680
[TBL] [Abstract][Full Text] [Related]
2. Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence.
Angelini PD; Zacarias Fluck MF; Pedersen K; Parra-Palau JL; Guiu M; Bernadó Morales C; Vicario R; Luque-García A; Navalpotro NP; Giralt J; Canals F; Gomis RR; Tabernero J; Baselga J; Villanueva J; Arribas J
Cancer Res; 2013 Jan; 73(1):450-8. PubMed ID: 23288917
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the role of the ADAM17-dependent secretome in cell signaling.
Kawahara R; Lima RN; Domingues RR; Pauletti BA; Meirelles GV; Assis M; Figueira AC; Paes Leme AF
J Proteome Res; 2014 Apr; 13(4):2080-93. PubMed ID: 24625128
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
Zheng X; Jiang F; Katakowski M; Kalkanis SN; Hong X; Zhang X; Zhang ZG; Yang H; Chopp M
Cancer Sci; 2007 May; 98(5):674-84. PubMed ID: 17355261
[TBL] [Abstract][Full Text] [Related]
5. Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding.
Effenberger T; von der Heyde J; Bartsch K; Garbers C; Schulze-Osthoff K; Chalaris A; Murphy G; Rose-John S; Rabe B
FASEB J; 2014 Nov; 28(11):4847-56. PubMed ID: 25077560
[TBL] [Abstract][Full Text] [Related]
6. Effect of cellular senescence on the growth of HER2-positive breast cancers.
Zacarias-Fluck MF; Morancho B; Vicario R; Luque Garcia A; Escorihuela M; Villanueva J; Rubio IT; Arribas J
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25972601
[TBL] [Abstract][Full Text] [Related]
7. Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer.
Sharma A; Bender S; Zimmermann M; Riesterer O; Broggini-Tenzer A; Pruschy MN
Clin Cancer Res; 2016 Sep; 22(17):4428-39. PubMed ID: 27076628
[TBL] [Abstract][Full Text] [Related]
8. Secretome analysis of ionizing radiation-induced senescent cancer cells reveals that secreted RKIP plays a critical role in neighboring cell migration.
Han NK; Kim BC; Lee HC; Lee YJ; Park MJ; Chi SG; Ko YG; Lee JS
Proteomics; 2012 Sep; 12(18):2822-32. PubMed ID: 22833545
[TBL] [Abstract][Full Text] [Related]
9. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
10. Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event.
Parr-Sturgess CA; Rushton DJ; Parkin ET
Biochem J; 2010 Dec; 432(2):283-94. PubMed ID: 20819075
[TBL] [Abstract][Full Text] [Related]
11. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
[TBL] [Abstract][Full Text] [Related]
12. Hydroquinone-induced miR-122 down-regulation elicits ADAM17 up-regulation, leading to increased soluble TNF-α production in human leukemia cells with expressed Bcr/Abl.
Chen YJ; Chang LS
Biochem Pharmacol; 2013 Sep; 86(5):620-31. PubMed ID: 23791922
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity.
Düsterhöft S; Michalek M; Kordowski F; Oldefest M; Sommer A; Röseler J; Reiss K; Grötzinger J; Lorenzen I
Biochemistry; 2015 Sep; 54(38):5791-801. PubMed ID: 26348730
[TBL] [Abstract][Full Text] [Related]
14. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights into the multilayered regulation of ADAM17: The role of the extracellular region.
Grötzinger J; Lorenzen I; Düsterhöft S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2088-2095. PubMed ID: 28571693
[TBL] [Abstract][Full Text] [Related]
16. HDLs activate ADAM17-dependent shedding.
Tellier E; Canault M; Poggi M; Bonardo B; Nicolay A; Alessi MC; Nalbone G; Peiretti F
J Cell Physiol; 2008 Mar; 214(3):687-93. PubMed ID: 17786981
[TBL] [Abstract][Full Text] [Related]
17. Taiwan cobra phospholipase A2 elicits posttranscriptional up-regulation of ADAM17 in human neuroblastoma SK-N-SH cells.
Liu WH; Chen KC; Chiou YL; Lin SR; Chang LS
J Cell Biochem; 2010 Sep; 111(1):148-57. PubMed ID: 20506406
[TBL] [Abstract][Full Text] [Related]
18. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
[TBL] [Abstract][Full Text] [Related]
19. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
[TBL] [Abstract][Full Text] [Related]
20. The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9.
Gutiérrez-López MD; Gilsanz A; Yáñez-Mó M; Ovalle S; Lafuente EM; Domínguez C; Monk PN; González-Alvaro I; Sánchez-Madrid F; Cabañas C
Cell Mol Life Sci; 2011 Oct; 68(19):3275-92. PubMed ID: 21365281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
